Trexquant Investment LP Mersana Therapeutics, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $309,172 - $542,596	-77,293 Reduced 49.0%	80,438 $330,000
Q4 2022 Feb 13, 2023	BUY	$5.65 - $7.86 $354,712 - $493,458	62,781 Added 66.12%	157,731 $924,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $439,618 - $759,600	94,950 New	94,950 $642,000
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $154,525 - $273,931	-41,317 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $226,417 - $407,385	41,317 New	41,317 $257,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $194M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.